Client News

Ergomed plc: Interim results for the six months ended 30 June 2019

Ergomed plc: Board Change

Apogenix AG: ESMO and Apogenix Collaborate on “Recurrent Glioblastoma Management: Challenges and Opportunities” Colloquium

Apogenix AG: Publication in Human Vaccines & Immunotherapeutics Illustrates the Advantages of Hexavalent CD40 Agonists in Targeting CD40 in Immuno-Oncology

Molecular Health to present at upcoming congresses

MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019)

Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory

Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project

Imcyse SA: Imcyse to present first-in-human phase 1b study results in type 1 diabetes at EASD 2019

Ergomed plc: Board Change